CIK 0001072379
- Non-accelerated filer
- Smaller reporting company
NORTHWEST BIOTHERAPEUTICS INC
Sign in to watch- Ticker
- NWBO
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943306718
- Phone
- +1 240-497-9024
- Business address
- 4800 MONTGOMERY LANE, SUITE 800, BETHESDA, MD, 20814
- 4 Open-market buy Director bought 10,000 shares at $0.00 ($10)
- 4 Open-market buy Director bought 79,317 shares at an average $5.16 ($409,294)
- 4 Open-market buy Director bought 135,417 shares at $5.60 ($758,335)
- 4/A Open-market sale 10% owner sold 548,273 shares at an average $4.42 ($2,423,981)
- 4/A Open-market sale 10% owner sold 678,858 shares at an average $3.17 ($2,153,674)
- 4 Open-market sale 10% owner sold 548,273 shares at an average $4.42 ($2,423,981)
- 4 Open-market sale 10% owner sold 678,858 shares at an average $3.17 ($2,153,674)
- 4 Open-market buy 10% owner bought 6,891,550 shares at $4.00 ($11,608,288)
- 4 Open-market sale 10% owner sold 860,000 shares at $1.08 ($928,800)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chairperson, CEO bought 6,468,153 shares
- 4 Gift Chairperson, CEO gave 950,000 shares (gift)
- 4 Gift Chief Scientific Officer gave 210,935 shares (gift)
- 4 Derivatives Options or other derivatives
- 4/A Gift Director gave 950,000 shares (gift)
- 4 Gift Chief Executive Officer gave 60,000 shares (gift)
- 4 Grant or award Chief Executive Officer acquired 243,432 shares (grant or award)
- 4 Gift Director gave 950,000 shares (gift)
- 4 Open-market sale Director sold 750,000 shares at an average $0.93 ($697,489)
- 4 Gift Chief Executive Officer gave 260,007 shares (gift)
Page 3 of 6 · 107 filings